Karolinska Institutet26 мар., 19:28Link to publication: ard.eular.org/article/S000...Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serumDermatomyositis (DM) is characterised by systemic inflammation, debilitating muscle weakness, cutaneous lesions, and increased mortality. An upregulation of type I interferon (IFN)-stimulated genes is...ard.eular.org